BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19017279)

  • 21. Investigation of the SH3BP2 gene mutation in cherubism.
    Lee JY; Jung YS; Kim SA; Lee SH; Ahn SG; Yoon JH
    Acta Med Okayama; 2008 Jun; 62(3):209-12. PubMed ID: 18596838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cherubism - new hypotheses on pathogenesis and therapeutic consequences.
    Hyckel P; Berndt A; Schleier P; Clement JH; Beensen V; Peters H; Kosmehl H
    J Craniomaxillofac Surg; 2005 Feb; 33(1):61-8. PubMed ID: 15694152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gene mutation and expression of SH-3BP-2 in cherubism].
    Li YW; Meng XM; Yu SF; Gao P
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Apr; 44(4):227-31. PubMed ID: 19576004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. So-called hybrid central odontogenic fibroma/central giant cell lesion of the jaws. A report on seven additional cases, including an example in a patient with cherubism, and hypotheses on the pathogenesis.
    Tosios KI; Gopalakrishnan R; Koutlas IG
    Head Neck Pathol; 2008 Dec; 2(4):333-8. PubMed ID: 20614305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genetic aspects of cherubism].
    Brix M; Peters H; Ranfaing E; Ricbourg B
    Rev Stomatol Chir Maxillofac; 2006 Apr; 107(2):105-8. PubMed ID: 16738517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism.
    Lo B; Faiyaz-Ul-Haque M; Kennedy S; Aviv R; Tsui LC; Teebi AS
    Am J Med Genet A; 2003 Aug; 121A(1):37-40. PubMed ID: 12900899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deactivating germline mutations in LEMD3 cause osteopoikilosis and Buschke-Ollendorff syndrome, but not sporadic melorheostosis.
    Mumm S; Wenkert D; Zhang X; McAlister WH; Mier RJ; Whyte MP
    J Bone Miner Res; 2007 Feb; 22(2):243-50. PubMed ID: 17087626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and genetic analysis of patients with cherubism.
    Machado RA; Pontes H; Pires FR; Silveira HM; Bufalino A; Carlos R; Tuji FM; Alves D; Santos-Silva AR; Lopes MA; Capistrano HM; Coletta RD; Fonseca FP
    Oral Dis; 2017 Nov; 23(8):1109-1115. PubMed ID: 28644570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cherubism: regression of the lesions and spontaneous bone regeneration].
    Timosca GC
    Rev Stomatol Chir Maxillofac; 1996; 97(3):172-7. PubMed ID: 8711332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cherubism].
    Brix M; Peters H; Lebeau J
    Rev Stomatol Chir Maxillofac; 2009 Nov; 110(5):293-8. PubMed ID: 19836038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative analysis of argyrophilic nuclear organizer regions in giant cell lesions of jaws.
    Sadri D; Hejazi M; Jahanbani J; Forouzandeh A
    J Oral Pathol Med; 2010 May; 39(5):431-4. PubMed ID: 20202088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages.
    Prod'Homme V; Boyer L; Dubois N; Mallavialle A; Munro P; Mouska X; Coste I; Rottapel R; Tartare-Deckert S; Deckert M
    J Clin Invest; 2015 Apr; 125(4):1396-400. PubMed ID: 25705883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOS1: a new player in the Noonan-like/multiple giant cell lesion syndrome.
    Hanna N; Parfait B; Talaat IM; Vidaud M; Elsedfy HH
    Clin Genet; 2009 Jun; 75(6):568-71. PubMed ID: 19438935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS).
    Gigante M; Pontrelli P; Montemurno E; Roca L; Aucella F; Penza R; Caridi G; Ranieri E; Ghiggeri GM; Gesualdo L
    Nephrol Dial Transplant; 2009 Jun; 24(6):1858-64. PubMed ID: 19131354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WWOX expression in giant cell lesions of the jaws.
    Amaral FR; Diniz MG; Bernardes VF; Souza PE; Gomez RS; Gomes CC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):210-3. PubMed ID: 23849374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of two novel mutations that produce acute intermittent porphyria: A 3-base deletion (841-843delGGA) and a missense mutation (T35M).
    De Siervi A; Weiss Cádiz DE; Parera VE; del C Batlle AM; Rossetti MV
    Hum Mutat; 2000 Oct; 16(4):373. PubMed ID: 11013452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [SH3BP2 heterozygous mutation amplifies macrophage inflammatory responses to infection in a mouse model of cherubism].
    Deckert M; Prod'Homme V
    Med Sci (Paris); 2015; 31(6-7):589-91. PubMed ID: 26152156
    [No Abstract]   [Full Text] [Related]  

  • 38. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variable expressivity familial cherubism: woman transmitting cherubism without suffering the disease.
    Pérez-Sayáns M; Barros-Angueira F; Suárez-Peñaranda JÉ; García-García A
    Head Face Med; 2013 Nov; 9():33. PubMed ID: 24382142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of SH3BP2 in the pathophysiology of cherubism.
    Reichenberger EJ; Levine MA; Olsen BR; Papadaki ME; Lietman SA
    Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S5. PubMed ID: 22640988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.